Chemotherapy regimens and treatment protocols for laryngeal cancer

Missak Haigentz, Carl E. Silver, Dana M. Hartl, Robert P. Takes, Juan P. Rodrigo, K. Thomas Robbins, Alessandra Rinaldo, Alfio Ferlito

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Importance of the field: Laryngeal cancer has been the model of curative-intent organ-preserving therapies in clinical oncology. Although the optimal care of patients with laryngeal cancer is truly multidisciplinary, with progressive advances in surgical, radiation, and medical oncology, the development of effective systemic therapies has been a major component of the therapeutic arsenal against laryngeal cancer. Areas covered in this review: This review will discuss the rapidly evolving roles of chemotherapy in the management of locally advanced and metastatic laryngeal cancer. What the reader will gain: The reader will gain a historical perspective on this evolution in treatment and will appreciate current treatment challenges and promising future directions in optimizing therapeutic efficacy in functional larynx preservation and in patient survival. Take home message: The treatment of most patients with laryngeal cancer with systemic therapy represents an opportunity to positively impact functional outcomes with an anatomically and functionally preserved larynx. Future challenges include identification of novel therapies and optimizing therapy protocols for individualized patient care.

Original languageEnglish (US)
Pages (from-to)1305-1316
Number of pages12
JournalExpert Opinion on Pharmacotherapy
Volume11
Issue number8
DOIs
StatePublished - Jun 1 2010
Externally publishedYes

Fingerprint

Laryngeal Neoplasms
Clinical Protocols
Drug Therapy
Therapeutics
Medical Oncology
Larynx
Patient Care
Radiation Oncology

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Haigentz, M., Silver, C. E., Hartl, D. M., Takes, R. P., Rodrigo, J. P., Robbins, K. T., ... Ferlito, A. (2010). Chemotherapy regimens and treatment protocols for laryngeal cancer. Expert Opinion on Pharmacotherapy, 11(8), 1305-1316. https://doi.org/10.1517/14656561003749256
Haigentz, Missak ; Silver, Carl E. ; Hartl, Dana M. ; Takes, Robert P. ; Rodrigo, Juan P. ; Robbins, K. Thomas ; Rinaldo, Alessandra ; Ferlito, Alfio. / Chemotherapy regimens and treatment protocols for laryngeal cancer. In: Expert Opinion on Pharmacotherapy. 2010 ; Vol. 11, No. 8. pp. 1305-1316.
@article{5c3d360a1aff4ebeaab7b5d10332a807,
title = "Chemotherapy regimens and treatment protocols for laryngeal cancer",
abstract = "Importance of the field: Laryngeal cancer has been the model of curative-intent organ-preserving therapies in clinical oncology. Although the optimal care of patients with laryngeal cancer is truly multidisciplinary, with progressive advances in surgical, radiation, and medical oncology, the development of effective systemic therapies has been a major component of the therapeutic arsenal against laryngeal cancer. Areas covered in this review: This review will discuss the rapidly evolving roles of chemotherapy in the management of locally advanced and metastatic laryngeal cancer. What the reader will gain: The reader will gain a historical perspective on this evolution in treatment and will appreciate current treatment challenges and promising future directions in optimizing therapeutic efficacy in functional larynx preservation and in patient survival. Take home message: The treatment of most patients with laryngeal cancer with systemic therapy represents an opportunity to positively impact functional outcomes with an anatomically and functionally preserved larynx. Future challenges include identification of novel therapies and optimizing therapy protocols for individualized patient care.",
author = "Missak Haigentz and Silver, {Carl E.} and Hartl, {Dana M.} and Takes, {Robert P.} and Rodrigo, {Juan P.} and Robbins, {K. Thomas} and Alessandra Rinaldo and Alfio Ferlito",
year = "2010",
month = "6",
day = "1",
doi = "10.1517/14656561003749256",
language = "English (US)",
volume = "11",
pages = "1305--1316",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "8",

}

Haigentz, M, Silver, CE, Hartl, DM, Takes, RP, Rodrigo, JP, Robbins, KT, Rinaldo, A & Ferlito, A 2010, 'Chemotherapy regimens and treatment protocols for laryngeal cancer', Expert Opinion on Pharmacotherapy, vol. 11, no. 8, pp. 1305-1316. https://doi.org/10.1517/14656561003749256

Chemotherapy regimens and treatment protocols for laryngeal cancer. / Haigentz, Missak; Silver, Carl E.; Hartl, Dana M.; Takes, Robert P.; Rodrigo, Juan P.; Robbins, K. Thomas; Rinaldo, Alessandra; Ferlito, Alfio.

In: Expert Opinion on Pharmacotherapy, Vol. 11, No. 8, 01.06.2010, p. 1305-1316.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Chemotherapy regimens and treatment protocols for laryngeal cancer

AU - Haigentz, Missak

AU - Silver, Carl E.

AU - Hartl, Dana M.

AU - Takes, Robert P.

AU - Rodrigo, Juan P.

AU - Robbins, K. Thomas

AU - Rinaldo, Alessandra

AU - Ferlito, Alfio

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Importance of the field: Laryngeal cancer has been the model of curative-intent organ-preserving therapies in clinical oncology. Although the optimal care of patients with laryngeal cancer is truly multidisciplinary, with progressive advances in surgical, radiation, and medical oncology, the development of effective systemic therapies has been a major component of the therapeutic arsenal against laryngeal cancer. Areas covered in this review: This review will discuss the rapidly evolving roles of chemotherapy in the management of locally advanced and metastatic laryngeal cancer. What the reader will gain: The reader will gain a historical perspective on this evolution in treatment and will appreciate current treatment challenges and promising future directions in optimizing therapeutic efficacy in functional larynx preservation and in patient survival. Take home message: The treatment of most patients with laryngeal cancer with systemic therapy represents an opportunity to positively impact functional outcomes with an anatomically and functionally preserved larynx. Future challenges include identification of novel therapies and optimizing therapy protocols for individualized patient care.

AB - Importance of the field: Laryngeal cancer has been the model of curative-intent organ-preserving therapies in clinical oncology. Although the optimal care of patients with laryngeal cancer is truly multidisciplinary, with progressive advances in surgical, radiation, and medical oncology, the development of effective systemic therapies has been a major component of the therapeutic arsenal against laryngeal cancer. Areas covered in this review: This review will discuss the rapidly evolving roles of chemotherapy in the management of locally advanced and metastatic laryngeal cancer. What the reader will gain: The reader will gain a historical perspective on this evolution in treatment and will appreciate current treatment challenges and promising future directions in optimizing therapeutic efficacy in functional larynx preservation and in patient survival. Take home message: The treatment of most patients with laryngeal cancer with systemic therapy represents an opportunity to positively impact functional outcomes with an anatomically and functionally preserved larynx. Future challenges include identification of novel therapies and optimizing therapy protocols for individualized patient care.

UR - http://www.scopus.com/inward/record.url?scp=77952118528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952118528&partnerID=8YFLogxK

U2 - 10.1517/14656561003749256

DO - 10.1517/14656561003749256

M3 - Review article

VL - 11

SP - 1305

EP - 1316

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 8

ER -